The emerging role of gastrointestinal organ transplantation

Clinics in Family Practice

Volumn 6, Issue 3, 2004, Pages 775-791

  Dove, Lorna ^a   Brown, Robert ^a  

^a Howard Hughes Medical Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIFUNGAL AGENT; ANTIMITOTIC AGENT; ANTIVIRUS AGENT; AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN; ERYTHROMYCIN; FLUCONAZOLE; IMMUNOSUPPRESSIVE AGENT; INFLUENZA VACCINE; ISONIAZID; LIVE VACCINE; LOPINAVIR; MACROLIDE; MEASLES MUMPS RUBELLA VACCINE; METOCLOPRAMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PNEUMOCOCCUS VACCINE; PROPYLTHIOURACIL; PROTEINASE INHIBITOR; PYRROLE DERIVATIVE; RITONAVIR; STEROID; TACROLIMUS; UNINDEXED DRUG; VORICONAZOLE;

AMANITA PHALLOIDES; CLINICAL TRIAL; DIGESTIVE SYSTEM FUNCTION DISORDER; DRUG BLOOD LEVEL; DRUG METABOLISM; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SURGERY; GRAFT REJECTION; HEALTH PRACTITIONER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; MEDICAL SPECIALIST; MORBIDITY; ORGAN TRANSPLANTATION; PANCREAS TRANSPLANTATION; PATIENT REFERRAL; POSTOPERATIVE CARE; POSTOPERATIVE INFECTION; PREOPERATIVE CARE; QUALITY OF LIFE; REVIEW; SURGEON; SURGICAL RISK; SURVIVAL; TREATMENT INDICATION;

EID: 4344637582     PISSN: 15225720     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cfp.2004.04.001     Document Type: Review

References (47)

1. Steinman T. Becker B. Frost A. Olthoff K.M. Smart F.W. Suki W.N. et al. Guidelines for the referral and management of patient's eligible for solid organ transplantation Transplantation 71 2001 1189-1204
2. Newton S. Promoting adherence to transplant medication regimens: a review of behavioral analysis J Transpl Coord 9 1999 13
3. Mazzaferro V. Regalia E. Doci R. Andreola S. Pulvirenti A. Bozzetti F. et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 1996 693-699
4. Mor E. Kaspar R. Sheiner P. Schwartz M. Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation Ann Intern Med 129 1998 643-653
5. Consensus statement on indications for liver transplantation: Paris, June 22-23, 1993 Hepatology 20 1994 63S-68S
6. Lidofsky S.D. Bass N.M. Prager M.C. Washington D.E. Read A.E. Wright T.L. et al. Intracranial pressure monitoring and liver transplantation for fulminant hepatic failure Hepatology 16 1 1992 1-7
7. Rave S. Tilanus H. Van der Linden J. de Man R.A. van der Berg B. Hop W.C. et al. The importance of orthotopic liver transplantation in acute hepatic failure Transpl Int 15 2002 29-33
8. Zakim D. Boyer T. Hepatology: a textbook of liver disease 4th edition 2002 W.B. Saunders Philadelphia
9. Ostapowicz G. Fontana R. Schiodt F. Larson A. Davern T.J. Han S.H. et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States Ann Intern Med 137 2002 947-954
10. United Network for Organ Sharing (UNOS). Allocation of livers. Available at: www.unos.org . Accessed December 28, 2003
11. O'Grady J. Schalm S. Williams R. Early indicators of prognosis in fulminant hepatic failure Gastroenterology 97 1989 439-445
12. De Jongh F.E. Janssen H.L.A. De Man R.A. Hop W.C.J. Schalm S.W. van Blankenstein M. Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver Gastroenterology 103 1992 1630-1635
13. Fattovich G. Giustina G. Degos F. Tremolada F. Diodati G. Almasio P. et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients Gastroenterology 112 1997 463-472
14. Wiesner R. Edwards E. Freeman R. Harper A. Kim R. Kamath P. et al. Model for end-stage liver disease (MELD) and allocation of donor livers Gastroenterology 124 2003 91-96
15. Kamath P. Wiesner R. Malinchoc M. Kremers W. Therneau T.M. Kosberg C.L. et al. A model to predict survival in patients with end-stage liver disease Hepatology 33 2001 464-470
16. Gines P. Quintero E. Arroyo V. Compensated cirrhosis: natural history and prognostic factors Hepatology 7 1987 122-128
17. Cronin D.C. Faust T. Brady C. Conjeevaram H. Jain S. Gupta P. et al. Modern immunosuppression Clin Liver Dis 4 2000 619-655
18. Fishman J. Rubin R. Infection in organ-transplant recipients N Engl J Med 338 1998 1741-1751
19. Winston D. Pakrasi A. Busuttil R. Prophylactic fluconazole in liver transplant recipients Ann Intern Med 131 1999 729-737
20. Dominguez E. Long-term infectious complications of liver transplantation Semin Liver Dis 15 1995 133-138
21. Singh N. Wagener M. Marino I. Gayowski T. Trends in invasive fungal infections in liver transplant recipients: correlation with evolution in transplantation practices Transplantation 73 2002 63-67
22. Munoz S. Rothstein K. Reich D. Manzarbeitia C. Long-term care of the liver transplant recipient Clin Liver Dis 4 2000 691-710
23. Duvoux C. Pageaux G. Vanlemens C. Roudot-Thoraval F. Vincens-Rolland A.L. Hezode C. et al. Risk factors for lymphoproliferative disorders after liver transplantation in adults: an analysis of 480 patients Transplantation 74 2002 1103-1109
24. Bueno J. Ramil C. Somoza I. Sanchez-Galindo A. Solar A. Arnal F. et al. Treatment of monomorphic B-cell lymphoma with rituximab after liver transplantation in a child Pediatr Transplant 7 2003 153-156
25. Berg D. Otley C. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management J Am Acad Dermatol 47 2002 1-17
26. Atassi T. Thuluvath P. Risk of colorectal adenoma in liver transplant recipients compared to immunocompetent control population undergoing routine screening colonoscopy J Clin Gastroenterol 37 2003 72-73
27. Yee G. McGuire T. Pharmacokinetic drug interactions with cyclosporin (parts I and II) Clin Pharmacokinet 19 1990 400-415
28. Jain A. Venkataramanan R. Eghtesad B. Marcos A. Ragni M. Shapiro R. et al. Effect of coadministered lopinavir and ritonavir (Kaletra) on tacrolimus blood concentration in liver transplantation patients Liver Transpl 9 2003 954-960
29. Pai M. Allen S. Voriconazole inhibition of tacrolimus metabolism Clin Infect Dis 36 2003 1089-1091
30. Brown R. Jr. Russo M. Lai M. Shiffman M.L. Richardson M.C. Everhart J.E. et al. A survey of liver transplantation from living adult donors in the United States N Engl J Med 348 2003 818-825
31. Ghanekar A. Grant D. Small bowel transplantation Curr Opin Crit Care 7 2001 133-137
32. Goulet O. Lacaille F. Jan D. Ricour C. Intestinal transplantation: indications, results, and strategy Curr Opin Clin Nutr Metab Care 3 2000 329-338
33. Buchman A. Scolapio J. Fryer J. AGA Technical review on short bowel syndrome and intestinal transplantation Gastroenterology 124 2003 1111-1134
34. Gerber D. Intestinal transplantation. Available at: Medscape.com . Accessed December 28, 2003.
35. Abu-Elmagd K. Reyes J. Bond G. Mazariegos G. Wu T. Murase N. et al. Clinical intestinal transplantation: a decade of experience at a single center Ann Surg 234 2001 404-417
36. Mueller A. Pascher A. Platz K. Nussler N.C. Schulz R.J. Horch D. et al. Modified surgical technique in clinical small bowel transplantation: donor and recipient management Transplant Proc 34 2002 2265-2267
37. Cicalese L. Pierpaolo S. Green M. Abu-Elmagd K. Kocoshis S. Reyes J. Bacterial translocation in clinical intestinal transplantation Transplantation 71 2001 1414-1417
38. Sutherland D. Rainer W. Gruessner W. Gruessner A. Pancreas transplantation for treatment of diabetes mellitus World J Surg 25 2001 487-496
39. Odorico J. Sollinger H. Technical and immunosuppressive advances in transplantation for insulin-dependent diabetes mellitus World J Surg 26 2002 194-211
40. Fioretto P. Steffes M. Sutherland D. Goetz F. Mauer M. Reversal of lesions of diabetic nephropathy after pancreas transplantation N Engl J Med 339 1998 69-75
41. Coppelli A. Giannarelli R. Mariotti R. Rondinini L. Fossati N. Vistoli F. et al. Pancreas transplant alone determines early improvement of cardiovascular risk factors and cardiac function in type 1 diabetic patients Transplantation 76 2003 974-976
42. Gruessner A. Sutherland D. Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network of Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) Clin Transpl 2002 41-77
43. Humar A. Khwaja K. Ramcharan T. Asolati M. Kandaswamy R. Gruessner R.W. et al. Chronic rejection: the next major challenge for pancreas transplant recipients Transplantation 76 2003 918-923
44. Liu E. Herold K. Transplantation of the islets of langerhans: new hope for treatment of type 1 diabetes mellitus Trends Endocrinol Metab 11 2000 379-382
45. Shapiro A. Ryan E. Lakey J. Islet cell transplantation Lancet 358 Suppl 2001 s21
46. Ault A. Edmonton's islet success tough to duplicate elsewhere Lancet 361 2003 2054
47. Casey J. Lakey J. Ryan E. Paty B.W. Owen R. O'Kelly K. et al. Portal venous pressure changes after sequential clinical islet transplantation Transplantation 74 2002 913-915